| For: | Xu TC, Liu Y, Yu Z, Xu B. Gut-targeted therapies for type 2 diabetes mellitus: A review. World J Clin Cases 2024; 12(1): 1-8 [PMID: 38292634 DOI: 10.12998/wjcc.v12.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i1/1.htm |
| Number | Citing Articles |
| 1 |
Ewelina Młynarska, Jakub Wasiak, Agata Gajewska, Greta Steć, Joanna Jasińska, Jacek Rysz, Beata Franczyk. Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management—A Narrative Review. Nutrients 2024; 16(12) doi: 10.3390/nu16121938
|
| 2 |
Aditi Singh, Sucharita Shadangi, Pulkit Kr. Gupta, Soumendra Rana. Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies. Comprehensive Physiology 2025; 15(1) doi: 10.1002/cph4.70003
|
| 3 |
Hassan Barakat, Sally S. Sakr, Hani A. Alfheeaid, Khalid A. Alsaleem, Raghad M. Alhomaid, Tamer M. El-Messery, Tarek A. Ebeid, Essam Y. Abdul-Hafeez. Oxidative Stress–Gut Microbiome Crosstalk: Intestinal Redox Imbalance and Probiotics Therapeutic Potential. Antioxidants 2026; 15(5) doi: 10.3390/antiox15050533
|
| 4 |
Davini Clister, Qhelen Mayline Chandra, Michle William Tan, Mega Carensia Gunawan, Aasia Bibi, Amer Ahmed, Marianne Bastian, Pornphimon Meesakul, Shugeng Cao, Bonglee Kim, Fahrul Nurkolis, Rony Abdi Syahputra. Microbiome-Based Precision Interventions in Type 2 Diabetes Mellitus: Mechanisms, Modulators, and Translational Opportunities. The Journal of Nutrition 2026; doi: 10.1016/j.tjnut.2026.101596
|
| 5 |
Jinzhou Liu, Min Guo, Xiaobin Yuan, Xiao Fan, Jin Wang, Xiangying Jiao. Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN. Journal of Diabetes 2025; 17(4) doi: 10.1111/1753-0407.70068
|
| 6 |
Wiktoria Sielwanowska, Maciej Dubaj, Karol Bigosiński, Aleksandra Dembowska, Domnik Porada. FECAL MICROBIOTA TRANSPLANTATION: A REVOLUTIONARY THERAPY FOR METABOLIC DISORDERS. Health Problems of Civilization 2025; doi: 10.5114/hpc.2025.150238
|
| 7 |
Christos G. Nikolaidis, Despoina Gyriki, Elisavet Stavropoulou, Eleni Karlafti, Triantafyllos Didangelos, Christina Tsigalou, Anastasia Thanopoulou. Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1701504
|
| 8 |
Miao Wang, Qing Yang, Ye Li, Yang Zhao, Junbo Zou, Fei Luan, Xiujuan Peng, Zhuangzhuang Huang, Feng Liu. Therapeutic potential of traditional Chinese medicine and mechanisms for the treatment of type 2 diabetes mellitus. Chinese Medicine 2025; 20(1) doi: 10.1186/s13020-025-01222-x
|
| 9 |
力邦 邓. A Review on the Scope of Influencing Factors of Dietary Literacy in Patients with Type 2 Diabetes. Nursing Science 2026; 15(06) doi: 10.12677/ns.2026.156187
|
| 10 |
Yanan Jia, Qiaoyu Li, Fenglin Jiang, Xianzhi Huang, Lingshu Zeng, Yuansong Zhang, Li Xu. Ultrasonic degradation of mulberry twigs polysaccharides: Effect on in vitro hypoglycemic activity and prebiotic potential. International Journal of Biological Macromolecules 2025; 310 doi: 10.1016/j.ijbiomac.2025.143356
|
| 11 |
Yingqing Hu, Yanqiu Liang, Youyou Lv, Panwei Mu, Ying Wang, Dingbang Huang, Dezhao Liu. Causal relationship between gut microbiota and diabetic neuropathy: a Mendelian randomization and 16S rRNA sequencing analysis. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1632406
|
| 12 |
Zheng Ye, Wenjing Wang, Yumei Li, Qiaoshuang Lu, Chun Yang. Preparation, Structural Characterization, and Synergistic Hypoglycemic Effect of Jujube Polysaccharide–Polyphenol Complex. Foods 2026; 15(3) doi: 10.3390/foods15030552
|
| 13 |
Xiaoyu Yin, Ziwei Liu, Gegentuya Huanood, Hayate Sawatari, Keiya Shimamori, Masahiro Kuragano, Kiyotaka Tokuraku. Analyzing Amylin Aggregation Inhibition Through Quantum Dot Fluorescence Imaging. International Journal of Molecular Sciences 2024; 25(20) doi: 10.3390/ijms252011132
|
| 14 |
Tianxiao Shen, Xinyue Tang, Yixin Pan, Hua He, Kejia Hu. Effect of vagus nerve stimulation on metabolism: a systematic review and meta-analysis. International Journal of Obesity 2025; 49(12) doi: 10.1038/s41366-025-01871-w
|
| 15 |
Aycan Gundogdu, Muzaffer Arikan, Alican Ulas, Seda Sevilay Koldaş, Gulfem Ece. From dysbiosis to therapy: Shared gut microbial signatures and targeted interventions across liver, heart and brain disorders. Next Research 2025; 2(4) doi: 10.1016/j.nexres.2025.100846
|
| 16 |
Asha Guraka, Alexandra C. Title, Isaac Thom Shawa, Wolfgang Moritz, Gyanendra Tripathi, Ali Kermanizadeh. An in vitro investigation of diet-influenced gut bacterial metabolites on the onset of Type 2 diabetes mellitus using a multi-cellular human primary islet model. NAM Journal 2026; 2 doi: 10.1016/j.namjnl.2026.100076
|
| 17 |
Asha Guraka, Marie Lush, Georgios Zouganelis, Joe Waldron, Subbareddy Mekapothula, Jinit Masania, Gareth Wynn Vaughan Cave, Myra Elizabeth Conway, Gyanendra Tripathi, Ali Kermanizadeh. Investigating the Role of Diet-Manipulated Gut Bacteria in Pathogenesis of Type 2 Diabetes Mellitus—An In Vitro Approach. Nutrients 2026; 18(2) doi: 10.3390/nu18020279
|
| 18 |
Ashutosh Tiwari, Dyah Ika Krisnawati, Erna Susilowati, Chinmaya Mutalik, Tsung-Rong Kuo. Next-Generation Probiotics and Chronic Diseases: A Review of Current Research and Future Directions. Journal of Agricultural and Food Chemistry 2024; 72(50) doi: 10.1021/acs.jafc.4c08702
|